INTRODUCTION
The production of different antinuclear autoantibodies by patients with rheumatic disease undergirds the assumption of an autoimmune pathogenesis. Certain of the antibodies correlate with diagnosis: anti-DNA antibody with systemic lupus erythematosus (SLE),' and anti-IgG antibody with rheumatoid arthritis. Furthermore, antibodies to a crude nucleoplasm extract, called the extractable nuclear antigen (ENA), which yield a speckled pattern on the fluorescent antinuclear antibody test (FANA), have been associated with particular clinical subsets of SLE (1); these include antibodies to Sm with classical systemic lupus erythematosus (2) , to ribonucleoprotein (RNP) with mixed connective tissue disease (3) , and to SS-B (Ha) with the sicca syndrome (4) .
These associations, however, have been challenged (5) (6) (7) (8) (9) . The lack of accord may be due to variation in preparations of ENA, in the array of autoantibodies present in the patients' sera, and in assay methods. Clinical-correlative studies have used impure and uncharacterized saline nuclear extracts as antigen source, many components of which react with sera of rheumatic disease patients. Common assays (hemagglutination, immunodiffusion, or counterimmunoelectrophoresis) do not clearly differentiate between specificities in reactive sera; specificity is inferred from cross reactivity with "reference" sera or loss of reactivity after enzyme treatment. Understanding the relationships between serological reactivities and their pathogenic, prognostic, and therapeutic implications will require (a) sufficient quantities of purified antigens, (b) demonstration of homogeneity of antibody specificity among sera that react with particular nucleoplasm components, and (c) a quantifiable assay that distinguishes between the multiple antigenic specificities that yield the speckled FANA (12) . Chromatin from calf thymus nuclei was prepared according to a modification of the method of Levy et al. (13 (14) . Electrofocused acrylamide strips were frozen by rapid immersion in liquid nitrogen using the support tray of the LKB staining kit and were stored at -20°C in an airtight container with dessicant. A typical run produced 24 identical electrofocused strips, one of which was stained for protein, another stained for nucleic acid, and the remaining 22 snap frozen for subsequent crossed immunoelectrophoresis.
Crossed immunoelectrophoresis. Crossed immunoelectrophoresis used frozen Pagplate strips according to LKB application note 269 with modifications (15) . The resulting precipitin patterns were visualized by dehydration and staining according to the procedure of Weeke (16) .
Preparative electrofocusing. Preparative flat bed electrofocusing using granulated gel was performed according to the LKB application note 198. The antigenic specificity contained in each separate fraction was determined by rocket immunoelectrophoresis.
Immunological determinations. Rocket immunoelectrophoresis and counterimmunoelectrophoresis were performed according to Weeke (16) and Kurata and Tan (17) (16, 22) . This linear relationship has previously formed the basis for quantitation of antigens using specific antibody as detecting reagent in this technique. In this study, however, we were seeking to identify the specificities and concentrations of unknown patient antibodies dispersed in the gel that react with known quantities of purified antigen. At constant antigen concentration, immunoprecipitate height is known to be inversely proportional to antibody concentration in the gel, but this relationship has not been quantitated. In the ENA system, we found an exponential decrease in the height of the immunoprecipitate as the antibody concentration in the gel was increased linearly (Fig. 1 ). This semilogarithmic relationship is not unique for the ENA system; recalculation of the data of Weeke (16) and Laurell (22) reveals an identical inverse semilogarithmic relationship between antiserum concentration in agarose gel and rocket height when antigen concentration is held constant.
This relationship is represented graphically in the insert of Fig. 1 . Semilogarithmic expression of serum concentration in agarose gel plotted against peak height results in linearity. This relationship has been found to hold for all anti-Sm, anti-RNP, and anti-Ha specificities tested. Thus a standard curve can be constructed with reference antisera and antigen, and the antibody concentration of unknown serum samples measured by comparison to the immunoprecipitate heights for known dilutions of the reference sera. Although this technique could quantitate ENA antibody using crude nucleoplasm as antigen, we sought to refine its use by isolating the individual antigenic components, which could then be tested individually in separate wells on the same plate to determine both antigenic specificity and antibody concentration in one step.
Identification of antigens in electrofocused nucleoplasm by crossed immunoelectrophoresis. Crossed immunoelectrophoresis of electrofocused nucleoplasm defined the pH range of each antigen system and assessed the uniformity of antibody specificities among antisera of different individuals. Fig. 2 shows the results of crossed immunoelectrophoresis of electrofocused nucleoplasm on agarose plates containing whole antiserum from four different patients. Fig. 2A Fig. 3 . The pH gradient is linear in the pH range, 4.0 to 8.5. Each fraction was assayed for antigen activity using reference antisera in the rocket technique. Appearing in Fig. 3 by rocket immunoelectrophoresis. The result was complete loss of reactivity with the RNP antisera but no loss with antibody to Sm. When 500 mg of nucleoplasm was digested with ribonuclease before preparative electrofocusing none of the 30 fractions was active against anti-RNP sera, but fractions within the pH range of 5.1 to 6.4 again reacted with antibody to Sm. Thus, the preparative and analytical electrofocusing data both demonstrated (a) that Sm activity is present without RNP activity in the pH range of 6.0 to 6.8, (b) that both antigens occur together in the pH range of 5.0 to 6.0, and (c) that SS-B (Ha) antigen can be separated from both Sm and RNP at pH 4.5-4.9.
Quantitation of antibody concentration and identification of antigenic specificity of patient sera by rocket immunoelectrophoresis using purified antigens. Having established that rocket immunoelectrophoresis can quantitate antibody concentration using crude ENA as antigen, we then sought to extend its utility toward the assignment of antigenic specificity by substituting antigens isolated by preparative electrofocusing. Fig. 4 illustrates the immunoprecipitate patterns obtained with a representative antiserum to RNP (4A) and a serum reactive with all three antigens (Fig. 4B ). (1-9) ; the use of uncharacterized nuclear extracts as antigen sources and multispecific patient antisera certainly contribute to this controversy. This paper describes the use of ENA antigens partially purified by preparative electrofocusing in a rocket immunoelectrophoretic assay using whole unfractionated patient antisera. Crossed immunoelectrophoresis results in distinctive immunoprecipitate patterns when analytically electrofocused antigens are electrophoresed directly into agarose containing different patient antisera. The patterns were reproducible for the multiple sera from 10 different patients and served to identify the pH range of each antigen. The discriminatory capacity of the technique was verified by Ouchterlony analysis, counterimmunoelectrophoresis using enzyme-treated antigens, and hemagglutination. Cell extracts inactive by the latter methods were nonreactive, as were FANA-negative sera. These data suggest that anti-Sm, anti-Ha, and anti-RNP antisera from different individuals consistently react with the same group of proteins and/or RNA species. Uniformity of antibody specificities between individuals with similar anti-ENA reactivities validates the use of purified antigens for clinical correlative studies.
Antigens separated by preparative electrofocusing retain their immunologic activity and can be generated in milligram quantities for use in clinical correlative studies. Rocket immunoelectrophoresis is based upon the electrophoretic migration of antigens through a gel impregnated with antiserum at a pH that minimizes the charge (migration) of the detecting antibody. As the antigens are driven through the gel they form soluble immune complexes that migrate more slowly than the free antigen. When the complexes aggregate and precipitate, a "rocket" is formed, and its height no longer changes with continued application of current. Unique precipitates are formed for each antigen-antibody system that facilitates the identification of antisera with multiple specificities. Rocket immunoelectrophoresis offers greater resolution and precision than other methods, yet demands technical expertise and standardized antigens for quantitation.
The rocket technique is 100-1,000 times as sensitive as Ouchterlony immunodiffusion but less sensitive than hemagglutination or counterimmunoelectrophoresis. The assay requires ug of antigen per well with 0.25-0.5 ml whole serum per 10 ml of agarose.
The prospective application of this technique to more precise clinical correlative studies may clarify the relationship between anti-ENA antibodies and disease attributes. Our retrospective analysis did not support an association between disease activity and antiSm, anti-RNP, or anti-Ha titer. We found no evidence for a relationship between antibody specificity and either disease severity, response to therapy, or particular end-organ involvement.
Furthermore, preparative electrofocusing techniques also open avenues for accurate characterization of the antigens, study of their biological and pathological roles, and exploration of their potential involvement in eukaryotic gene expression. The RNA components of Sm and RNP antigens (small nuclear RNA-Sn RNA) bear sequence homology to nucleotide sequences across splice junction boundaries of primary RNA transcripts (28) . Isolation of these Sn RNAs and their associated peptides in undenatured form would facilitate direct testing of their putative role in RNA processing. We have used these techniques to isolate and characterize the Sn RNP from growth hormoneproducing rat pituitary cells in vitro and will show elsewhere2 that these Sn RNPs specifically recognize intervening sequences of the cloned growth hormone gene.
